Arthroscopic Rotator Cuff Repair with UC-MSCs for Large to Massive Tears
ConditionRotator Cuff Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorKorea University Anam Hospital
About this trial
Safety Analysis of Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells in Patients Undergoing Rotator Cuff Repair for Massive or Large Rotator Cuff Tears
Eligibility criteria
Qualifiers
Male or female 19 years of age and older
Unilateral shoulder pain with a pain score of 4 or higher.
patients with a symptom duration of at least three months who have not responded to conventional treatments, including analgesics.
patients diagnosed with massive or extensive full-thickness rotator cuff tears confirmed by computed tomography arthrography or magnetic resonance imaging.
Disqualifiers
patients diagnosed with small or medium full-thickness rotator cuff tears among study participants with full-thickness rotator cuff tears.
patients who have received subacromial injection therapy in the affected shoulder within the past three months.
patients who have undergone rotator cuff surgery on the affected shoulder within the past six months.
patients exhibiting or suspected of having the following radiological findings: malignant tumors, severe glenohumeral osteoarthritis, or bony abnormalities causing subacromial space narrowing.
Trial design
Treatments tested in this trial
- Injection allogenic Umbilical Cord-derived Mesenchymal Stem Cell
Treatment groups
15 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov